Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

LiveOne Inc LVO

LiveOne, Inc. offers a creator-first, music, entertainment, and technology platform, which is focused on delivering premium experiences and content worldwide through memberships and live and virtual events. It operates through three segments: PodcastOne, Slacker, and Media Group. It provides services through an over-the-top application powered by Slacker (LiveOne App) called LiveOne. The Company is engaged in the acquisition, distribution and monetization of live music, Internet radio, podcasting and music-related streaming and video content. It is also engaged in packaging, producing, and broadcasting its live music content across its music platform. In addition, the Company has a distribution relationship with a variety of platforms, including Roku, AppleTV, Amazon Fire, linear over-the-top (OTT) platforms, such as STIRR, and XUMO. The Company's subsidiaries include Slacker Radio, PodcastOne, PPVOne, Palm Beach Records, CPS, LiveXLive, DayOne Music Publishing, Drumify, and Splitmind.


NDAQ:LVO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by ElliotGHon Aug 20, 2024 10:20am
24 Views
Post# 36187738

Pioneering New Osteosarcoma and Breast Cancer Treatment $OSX

Pioneering New Osteosarcoma and Breast Cancer Treatment $OSX
Pioneering New Osteosarcoma and Breast Cancer Treatments: Exclusive Interview with OS Therapies' CEO (NYSE-A: OSTX)

<< Previous
Bullboard Posts
Next >>